Minuti Agnese, Brufani Francesca, Menculini Giulia, Moretti Patrizia, Tortorella Alfonso
Department of Psychiatry, University of Perugia, Perugia, Italy.
Curr Res Neurobiol. 2022 Jun 14;3:100044. doi: 10.1016/j.crneur.2022.100044. eCollection 2022.
Gut microbiota regulates neurotransmission, neurogenesis, neuroinflammation, and neuroendocrine signaling. The aim of the present review is to analyze the literature concerning gut microbiota dysregulation and mood symptoms, with the specific hypothesis that such alterations play a role in the onset of mood disorders. Here, in fact, we review recent research focusing on how gut microbiota dysregulation influences the onset of mood disorders and on possible pathophysiological mechanisms involved in this interaction. We pay specific attention to the relationship between gut microbiota dysregulation and inflammatory state, Th17 differentiation, neuroactive factors, and TRP metabolism. The association between gut microbiota dysregulation and mood disorders is critically analyzed under a clinical point of view, also focusing on the emergence of mood symptoms in the context of medical conditions. These latter correlations may enable an interdisciplinary perspective in the clinical approach to such symptoms, as well as new treatment strategies, such as nutritional interventions, psychobiotics, antibiotics, as well as fecal microbiota transplantation.
肠道微生物群调节神经传递、神经发生、神经炎症和神经内分泌信号传导。本综述的目的是分析有关肠道微生物群失调与情绪症状的文献,具体假设是这种改变在情绪障碍的发病中起作用。事实上,在这里我们回顾了最近的研究,重点关注肠道微生物群失调如何影响情绪障碍的发病以及这种相互作用中可能涉及的病理生理机制。我们特别关注肠道微生物群失调与炎症状态、Th17分化、神经活性因子和色氨酸代谢之间的关系。从临床角度对肠道微生物群失调与情绪障碍之间的关联进行了批判性分析,同时也关注在医疗状况背景下情绪症状的出现。这些相关性可能为这类症状的临床治疗提供跨学科视角,以及新的治疗策略,如营养干预、心理益生菌、抗生素以及粪便微生物群移植。